The Advisory Committee on Immunization Practices (ACIP) recommends a single dose of zoster vaccine for immunocompetent adults 60 years of age and older, based on the results of this study ...
Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit vaccine -- Ten shingles cases would have been expected absent ...
ohsu.edu Current American College of Rheumatology guidelines conditionally recommend that patients with RA aged ≥50 years receive HZ vaccine prior to tofacitinib or bDMARDs.4 We previously evaluated ...
Healthcare providers recommend the shingles vaccine Shingrix (recombinant zoster vaccine) for people over 50. It's given in two doses, 2-6 months apart, and is 80-90% effective at preventing shingles.
Background Patients receiving JAK inhibitor drugs (JAKi) have an increased risk of herpes zoster (HZ). A new recombinant vaccine effective against HZ (Shingrix-RV) is currently recommended for ...